19 May 2013
Keywords: teva, regain, generics, spot, acquisition, ivax, israel
Article | 01 August 2005
Israel's Teva Pharmaceutical Industries has announced its largest-ever acquisition, with a $7.4 billion bid for US generics maker IVAX Corp.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 August 2005
17 May 2013
© 2013 thepharmaletter.com